Pacheco GMR, Chávez AD, Diez GMP, Miranda DA

Language: Spanish
References: 13
Page: 7-10
PDF size: 59.14 Kb.

ABSTRACT

Objective: To know the characteristics of the population of amputates for tumor in the National Rehabilitation Center (6 years). Material and methods: Review expedient’s amputees etiology tumoral from 1999 to 2005. Design: A retrospective, descriptive, transversal and observational study. Descriptive statistics and square Chi test: SPSS version 10 Windows. Results: Review 720 expedient’s, 53 amputees for tumor. Masculine (57%), female (43%). Age: the youngest 10 years and the oldest 74, 34 years old in average. Activities laboral before the diagnosis: employment (47%), student (28%), home (21%), unemployment (3.7%). After the diagnosis: Less people work (28%), student (15%), increment in home (26%) and unemployment (32%). Most frequent musculoskeletal Tumor osteosarcoma (60.3%). Reference Hospitals: INCAN (26.4%), CNR (26.4%), Pediatrics Hospital of Mexico (13.2%), H. Juárez Hospital (5.7%), Gea. Glz. Hospital (3.8%), Pediatrics National Institute. (1.9%). Evolution time tumor to time of the diagnosis: 1-5 years: (43.4%), lest 1 year (32.1%), more 10 years: (20.8%). Lower limb amputees (84.9%), Upper limb amputees (15.1%), amputate side right (51%), Chemotherapy: (66%). Adjuvant (62.3%), neoadjuvant (3.8%). Metastases (32%). Actual condition: died: (6%). Use prosthetics: 50.9%. Conclusions: Know the characteristics of the amputates population for musculoskeletal tumor. This characteristics suggest some risk factors for evaluating to late treatment and amputation. Vigilance groups of age with more risk.

REFERENCES

1. Bruce T et al. Limb salvage compared with amputation for osteosarcoma of the distal end of the femur. J Bone J Surg 1194; 76-A: 5.

2. Clarck M et al. Amputation for soft tissue sarcoma. Lancet Oncology 2003; 4: 6.

3. Ephrain P et al. Epidemiology of limb loss and congenital limb deficiency. A review of the literature. Arch Phys Med Rehabil 2003; 84: 747.

4. Fletcher. Diagnostic Histopathology of tumors. Second edition. Churchill-Livingstone, 2000.

5. Pohjolainen et al. Epidemiology of lower limb amputees in Southern Finland. 1995 since 1984.

6. Prosthet Orthot Int 1999; 23: 2-88.

7. Rommers G et al. Epidemiology of lower limb amputees in the north of Netherlands. A etiology, discharge destination and prosthetics use. Prosthet Orthot Int 1997; 21: 2-92.

8. Rooser B et al. Prognostication in soft tissue sarcoma. A model with four risk factors. Cancer 1988; 61: 817-821.

9. Rosenberg SA, Tepper J, Glatstein E. The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg 1982; 196: 305-15.

10. Sang Hoon Lee et al. Validation of a functional evaluation system in patients with musculoskeletal tumors. Clin Orthop Rel Resh 2003: 411.

11. Stewart CP et al. Cause of death of lower limb amputees. Prosthet Orthot Int 1992; 16: 2129.

12. Tamayo F et al. Incidencia de tumores óseos y de partes blandas. Rev Cubana Oncol 1999; 15: 3-165.

13. Wunder JS, Healey JH, Davis AM, Brennan MF. A comparison of staging systems for localized extremity soft tissue sarcoma. Cancer 2000; 88: 2721-30.